2016 Annual Meeting | Clinical Epilepsy III

Date Wednesday 04/20/16

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Topic(s)

Learning Objectives Participants should be able to recognize when a patient meets criteria for acute repetitive seizures, status epilepticus, and drug resistant epilepsy; know the latest therapeutic approaches to these patients in a variety of settings, including home, outpatient clinic, and hospital; recognize when to consider treatments in addition to AEDs and which ones to consider given a specific patient seizure type and clinical scenario; become more familiar with classifying seizures through video presentations.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
03:30 PM - 03:35 PM		Introduction
03:35 PM - 04:10 PM		Acute Repetitive Seizures and Status Epilepticus: From Home to the ICU and Back Suzette M. LaRoche, MD, FAAN
04:10 PM - 04:45 PM		Beyond AEDs - Surgery, Devices, Diet, or Marijuana? Elson L. So, MD, FAAN
04:45 PM - 05:20 PM		Video-EEG Case Presentations: You Make the Call William O. Tatum IV, DO, FAAN
05:20 PM - 05:30 PM		Questions and Answers

Faculty Disclosures
Suzette M. LaRoche, MD, FAAN	Dr. LaRoche has received intellectual property interests from a discovery or technology relating to health care. Dr. LaRoche has received publishing royalties from a publication relating to health care. Dr. LaRoche has a non-compensated relationship as a President with American Clinical Neurophysiology Society that is relevant to AAN interests or activities.
William O. Tatum IV, DO, FAAN	Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Elson L. So, MD, FAAN	Dr. So has nothing to disclose.

��ɫ��

��ɫ��